Abiopharma

Opaleye Management Inc. 🔴 sold 20.0K shares of HARROW, INC. (HROW) at $53.35 ($1.1M) Transaction Date: Jan 06, 2026 | Filing ID: 000965

Brennan Aoife 🟢 acquired 700.0K shares (1 derivative) of Climb Bio, Inc. (CLYM) at $3.81 ($2.7M) Transaction Date: Jan 06, 2026 | Filing ID: 007670

FRATES JAMES M 🔴 sold 3.3K shares of Amylyx Pharmaceuticals, Inc. (AMLX) at $11.11 Transaction Date: Jan 06, 2026 | Filing ID: 007669

Cohen Joshua B 🔴 sold 7.7K shares of Amylyx Pharmaceuticals, Inc. (AMLX) at $11.09 Transaction Date: Jan 06, 2026 | Filing ID: 007666

ALTSCHULLER Susan 🟢 acquired 142.5K shares (1 derivative) of Climb Bio, Inc. (CLYM) at $3.81 Transaction Date: Jan 06, 2026 | Filing ID: 007665

Klee Justin B. 🔴 sold 7.7K shares of Amylyx Pharmaceuticals, Inc. (AMLX) at $11.09 Transaction Date: Jan 06, 2026 | Filing ID: 007664

Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026

Driscoll Cindy 🟢 acquired 100.0K shares (1 derivative) of Climb Bio, Inc. (CLYM) at $3.81 Transaction Date: Jan 06, 2026 | Filing ID: 007662

Director SUN ANTHONY 🟡 adjusted position in 99.2K shares (7 derivative) of COGNEX CORP (CGNX) at $56.44 ($5.1M) Transaction Date: Jan 08, 2026 | Filing ID: 000002

Icecure Medical Ltd (ICCM) Files Form 6-K

RENTON HOLLINGS 🟢 acquired 9.5K shares (2 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 Transaction Date: Jan 06, 2026 | Filing ID: 000001

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook

Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance

BioMarin to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, at 11:15 am PT / 2:15 pm ET, in San Francisco, CA

ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025